Cover Image
市場調查報告書

全球非專利腫瘤科無菌注射劑市場:各產品(化療,單株抗體,细胞因子,胜肽激素),各疾病適應症(卵巢癌/乳癌,其他),各流通管道,各地區 - 趨勢與產業預測

Global Generic Oncology Sterile Injectable Market By Product Type, By Disease Indication, By Distribution Channel, and By Region - Trends and Forecast till 2015

出版商 Coherent Market Insights 商品編碼 593077
出版日期 內容資訊 英文 140 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球非專利腫瘤科無菌注射劑市場:各產品(化療,單株抗體,细胞因子,胜肽激素),各疾病適應症(卵巢癌/乳癌,其他),各流通管道,各地區 - 趨勢與產業預測 Global Generic Oncology Sterile Injectable Market By Product Type, By Disease Indication, By Distribution Channel, and By Region - Trends and Forecast till 2015
出版日期: 2017年11月28日 內容資訊: 英文 140 Pages
簡介

本報告提供全球非專利腫瘤科無菌注射劑市場相關調查,彙整市場概要和各產品,各疾病適應症,各流通管道,及各地區的趨勢,加入此市場的主要企業的簡介等資料。

第1章 調查目的與假設

第2章 市場概要

第3章 市場趨勢,法律規章,趨勢分析

  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 市場機會
  • 法律規章方案
  • 產業趨勢
  • 合併·收購
  • 新產品核可/上市
  • 宣傳與行銷主張

第4章 各產品市場

  • 簡介
  • 化療
  • 烷基劑
  • 抗代謝劑
  • 植物性生物鹼
  • 抗腫瘤抗生劑
  • 其他
  • 單株抗體
  • 细胞因子
  • 胜肽激素

第5章 各疾病適應症市場

  • 簡介
  • 卵巢癌
  • 乳癌
  • 肺癌
  • 胰臟癌
  • 其他

第6章 各流通管道市場

  • 簡介
  • 院內藥局
  • 零售藥局
  • 線上藥局

第7章 各地區預測

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東
  • 非洲

第8章 競爭環境

  • 熱圖分析
  • 企業簡介
  • 分析師的見解

第8章 章節

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Generic oncology sterile injectables are used in treatment of various types of cancers such as ovarian, breast, and lung. These drugs are relatively cheaper than branded counterparts. This is owing presence of same active ingredients, although its inactive contents are different. Cost is a major concern for cancer patients, especially in emerging economies such as India, Brazil, and China. Therefore, governments of such countries are taking efforts to reduce cost of medications and increase its accessibility. For instance, the National Pharmaceutical Pricing Authority (NPPA) of India reduced the prices of a few cancer drugs by 86% in March 2017. Generic oncology sterile injectables have a huge potential in such countries, where patient population is high; however, spending power is relatively low. Furthermore, patent expiry is expected to fuel growth of the generic oncology sterile injectables during the forecast period. Also, the emergence of biosimilars has also impacted growth of generics drugs. For instance, according to the Journal of Generics and Biosimilars Initiative, 2017, biosimilars had a major share in Europe since 2013 and in the U.S. since 2015 and the share of biosimilars is expected to increase significantly in the biologicals market. This is expected to eventually boost growth of the generic oncology sterile injectable market.

Market Dynamics

Generic oncology sterile injectables market is gaining significant traction due to rising prevalence of cancer cases. For instance, according to the National Cancer Institute, in 2016, around 1,685,210 new cases of cancers were reported in the U.S. Manufacturers are focusing on launching new products to offer low cost treatment to patients. For instance, in November, 2017, Mylan N.V. launched Clofarabine Injection (20 mg/20 mL (1 mg/mL) Single-Dose Vials) following U.S. Food and Drug administration approval in the U.S. market.  Clofarabine is a generic version of Genzyme's Clolar, which is used for treatment of refractory acute lymphoblastic leukemia for patients aged 1 year to 21 years.

Key features of the study:

This report provides in-depth analysis of the generic oncology sterile injectables market and its product type, market size (US$ Million), and Cumulative Annual Growth Rate (CAGR %) for the forecast period: 2017 – 2025, considering 2016as the base year.

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.

It profiles leading players in the generic oncology sterile injectables market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans.

Key companies covered as a part of this study include Eli Lilly & Company, Biocon Ltd., Baxter International Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., and Pfizer Inc.

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, distribution channel, market expansion, and marketing tactics.

The generic oncology sterile injectables market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for generic oncology sterile injectables market, research and consulting firms, new entrants and financial analysts.

Various strategy matrices used in analyzing the generic oncology sterile injectables market would provide stakeholders vital inputs to make strategic decisions accordingly.

Detailed Segmentation:

  • Global Generic Oncology Sterile Injectable Market, By Product Type:
  • Chemotherapy
  • Alkylating agents
  • Antimetabolites
  • Plant Alkaloids
  • Antitumor Antibiotics
  • Others
  • Monoclonal Antibodies
  • Cytokines
  • Peptide Hormones
  • Global Generic Oncology Sterile Injectable Market, By Disease Indication:
  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Others
  • Global Generic Oncology Sterile Injectable Market, By Distribution Channel :
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Generic Oncology Sterile Injectable Market, By Regions :
  • North America
  • By Product Type:
  • Chemotherapy
  • Alkylating agents
  • Antimetabolites
  • Plant Alkaloids
  • Antitumor Antibiotics
  • Others
  • Monoclonal Antibodies
  • Cytokines
  • Peptide Hormones
  • By Disease Indication:
  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Product Type:
  • Chemotherapy
  • Alkylating agents
  • Antimetabolites
  • Plant Alkaloids
  • Antitumor Antibiotics
  • Others
  • Monoclonal Antibodies
  • Cytokines
  • Peptide Hormones
  • By Disease Indication:
  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Brazil
  • Mexico
  • Rest of Latin America
  • Europe
  • By Product Type:
  • Chemotherapy
  • Alkylating agents
  • Antimetabolites
  • Plant Alkaloids
  • Antitumor Antibiotics
  • Others
  • Monoclonal Antibodies
  • Cytokines
  • Peptide Hormones
  • By Disease Indication:
  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type:
  • Chemotherapy
  • Alkylating agents
  • Antimetabolites
  • Plant Alkaloids
  • Antitumor Antibiotics
  • Others
  • Monoclonal Antibodies
  • Cytokines
  • Peptide Hormones
  • By Disease Indication:
  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Product Type:
  • Chemotherapy
  • Alkylating agents
  • Antimetabolites
  • Plant Alkaloids
  • Antitumor Antibiotics
  • Others
  • Monoclonal Antibodies
  • Cytokines
  • Peptide Hormones
  • By Disease Indication:
  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type:
  • Chemotherapy
  • Alkylating agents
  • Antimetabolites
  • Plant Alkaloids
  • Antitumor Antibiotics
  • Others
  • Monoclonal Antibodies
  • Cytokines
  • Peptide Hormones
  • By Disease Indication:
  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Eli Lilly & Company*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Future Plans
  • Biocon Ltd.
  • Baxter International Inc.
  • Hikma Pharmaceuticals PLC
  • Mylan N.V.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • “*” marked represents similar segmentation in other categories in the respective section

Table of Contents

  • Research Objective and assumption
  • Research Objectives
  • Assumptions
  • Abbreviations
  • Market Purview
  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Disease Indication
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)
  • Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Regulatory Scenario
  • Industry Trend
  • Merger and Acquisitions
  • New Product Approvals/Launch
  • Promotion and Marketing Initiatives
  • Global Generic Oncology Sterile Injectable Market, By Product Type, 2017 - 2025 (US$ Million)
  • Introduction
    • Market Share Analysis, 2017 and 2025 (%)
    • Y-O-Y Growth Analysis, 2015 - 2025
    • Segment Trends
  • Chemotherapy
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Alkylating agents
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Antimetabolites
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Plant Alkaloids
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Antitumor Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Monoclonal Antibodies
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Cytokines
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Peptide Hormones
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Global Generic Oncology Sterile Injectable Market, By Disease Indication, 2017 - 2025 (US$ Million)
  • Introduction
    • Market Share Analysis, 2017 and 2025 (%)
    • Y-O-Y Growth Analysis, 2015 - 2025
    • Segment Trends
  • Ovarian Cancer
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Breast Cancer
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Pancreatic Cancer
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Global Generic Oncology Sterile Injectable Market, By Distribution Channel, 2017 - 2025 (US$ Million)
  • Introduction
    • Market Share Analysis, 2017 and 2025 (%)
    • Y-O-Y Growth Analysis, 2015 - 2025
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  • Global Generic Oncology Sterile Injectable Market, By Regions, 2017 - 2025 (US$ Million)
  • Introduction
    • Market Share Analysis, By Region, 2017 and 2025 (%)
    • Y-o-Y Growth Analysis, For Regions, 2015 - 2025
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
  • Brazil
  • Mexico
  • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa
  • Competitive Landscape
  • Heat Map Analysis
  • Company Profiles
    • Eli Lilly & Company
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
    • Biocon Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
    • Baxter International Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
    • Hikma Pharmaceuticals PLC
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
    • Mylan N.V.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
    • Sandoz International GmbH
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
    • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
    • Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Future Plans
  • Section
  • References
  • Research Methodology
  • About us and Sales Contact
  • *Browse 28 market data tables and 25 figures on "Generic Oncology Sterile Injectable Market" - Global forecast to 2025".
Back to Top